After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Shadab Jakati, who went viral on social media with 'How much are 10 rupee biscuits', has recently
The US military attack on Venezuela and the capture of President Nicolás Maduro have shock
BJP media in-charge Amit Malviya attacked Rahul Gandhi via the social media platform X (formerly
Mumbai NCB zonal director Sameer Wankhede, who is probing the Aryan Khan drug case, himself seems
Xiaomi New Tabs: Xiaomi launches Mi Pad 5 and Mi Pad 5 Pro tablets, will compete with Samsung
Smartphone company Xiaomi has launched new tablets in China. The company has launched Mi Pad 5 an
With the onset of the winter season in India, the air quality has started deteriorating again. Th
In the Antilia case, the National Investigation Agency (NIA) on Wednesday presented former API Sa
There is a lot of speculation about the Asia Cup match to be played between India and Pakistan. I
The growing tension between Israel and Iran in West Asia has caught the attention of the whole wo
The hijab issue continues in Karnataka. Schools have been opened in the state from today itself.
